Pfizer (PFE) stock edges up as ViiV exit cash and Novavax vaccine-tech pact grab attention
New York, January 21, 2026, 14:11 EST — Regular session Pfizer shares gained roughly 0.8%, hitting $25.73 by Wednesday afternoon. The Health Care Select Sector SPDR ETF climbed around 1.2%, while the S&P 500 tracker SPY edged up about 0.5%. The move is modest, but investors are eager for clearer signals about Pfizer’s 2026 outlook after a rough patch for…